Bryan J. McMichael - 20 Jan 2023 Form 4 Insider Report for Coherus BioSciences, Inc. (CHRS)

Role
Title: Senior Vice President, Accounting, Corporate Controller and Principal Accounting Officer
Signature
/s/ McDavid Stilwell, as Attorney-in-Fact for Bryan J. McMichael
Issuer symbol
CHRS
Transactions as of
20 Jan 2023
Net transactions value
$0
Form type
4
Filing time
24 Jan 2023, 15:49:10 UTC
Previous filing
10 Jan 2023
Next filing
29 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CHRS Common Stock Award $0 +12,500 +90% $0.000000 26,386 20 Jan 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3 of the RSUs vest annually on January 20 of each year, with the first 1/3 vesting on January 20, 2024 and with the RSUs being fully vested on January 20, 2026, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

Remarks:

Title: Senior Vice President, Accounting, Corporate Controller and Principal Accounting Officer